About
Diabetes Treatment
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (12)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
110
By Phase
PHASE1: 1PHASE2: 2
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT04651959Lead Sponsor
Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions
PHASE1Unknown
30 participants
Started: Nov 13, 2020 · Completed: Dec 20, 2020
NCT05353686Lead Sponsor
A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes
PHASE2Completed
54 participants
Started: Feb 25, 2019 · Completed: Dec 19, 2019
NCT03278158Lead Sponsor
A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2
PHASE2Completed
26 participants
Started: Sep 18, 2017 · Completed: Nov 13, 2018
Locations (1)
Headquarters
Malmö, Sweden
Map
Loading map...